Cigarette smoking in long-term schizophrenia

European Psychiatry

Volumn 21, Issue 4, 2006, Pages 219-223

  Salokangas, R K R ^a   Honkonen, T ^b   Stengard E ^c   Koivisto, A M ^d   Hietala, J ^e  

^a Turku Psychiatric Clinic   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cigarette smoking; Gender; Hospital care; Neuroleptic medication; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX RATIO;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; COMORBIDITY; EDUCATIONAL STATUS; FEMALE; FINLAND; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MARITAL STATUS; MIDDLE AGED; PREVALENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX DISTRIBUTION; SMOKING; TIME; TIME FACTORS;

EID: 33745458101     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.07.008     Document Type: Article

References (33)

1. Brown S., Birtwistle J., Roe L., and Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 29 (1999) 697-701
2. Brown S., Inskip H., and Barraclough B. Causes of the excess mortality of schizophrenia. Brit J Psychiat 177 (2000) 212-217
3. Clarke P.B.S. Tobacco smoking, genes, and dopamine. Lancet 352 (1998) 84-86
4. Court J.A., Lloyd S., Thomas N., Piggott M.A., Marshall E.F., Morris C.M., et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87 (1998) 63-78
5. Dalack G.W., Becks L., Hill E., Pomerleau O.F., and Meador-Woodruff J.H. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21 (1999) 195-202
6. De Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., and Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 152 (1995) 453-455
7. Decina P., Caracci G., Sandik R., Berman W., Mukherjee S., and Scapicchio P. Cigarette smoking and neuroleptic-induced parkinsonism. Biol. Psychiatry 28 (1990) 502-508
8. Diwan A., Castine M., Pomerleau C.-S., Meador-Woodruff J.H., and Dalack G.W. Differential prevalence of cigarette smoking in patients with schizophrenic vs. mood disorders. Schizophr. Res. 33 (1998) 113-118
9. Doll R., Peto R., Wheatley K., and Gray R. Mortality in relation to smoking: 40 years' observation on British doctors. BMJ 309 (1994) 901-911
10. Endicott J., Spitzer R.L., Fleis J.L., and Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33 (1976) 766-771
11. George T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am. J. Psychiatry 157 (2000) 1835-1842
12. Glassman A.H. Cigarette smoking: implications for psychiatric illness. Am. J. Psychiatry 150 (1993) 546-553
13. Goff D.C., Henderson D.C., and Amica B.S. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 149 (1992) 1189-1194
14. Helakorpi S., Uutela A., Prättälä R., Berg A.-M., and Puska P. Suomalaisen aikuisväestön terveyskäyttäytyminen, kevät 1997 (Health behaviour of Finnish adult population; in Finnish) (1997), Kansanterveyslaitoksen julkaisuja B10, Helsinki
15. Herran A., de-Santiago A., Sandoya M., Fernandez M.J., Diez-Manrique J.F., and Vazquez-Barquero J.L. Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr. Res. 41 (2000) 373-381
16. Honkonen T., Saarinen S., and Salokangas R.K.R. Deinstitutionalization and schizophrenia in Finland II: discharged patients and their psychosocial functioning. Schizophr. Bull. 25 (1999) 547-555
17. Hughes J.R., Hatsukami D.K., Mitchell J.E., and Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143 (1986) 993-997
18. Itkin O., Nemets B., and Einat H. Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J. Clin. Psychiatry 62 (2001) 269-272
19. Iversen L.L. Smoking harmful to the brain. Nature 382 (1996) 206-207
20. Jann M., Saklad S.R., Ereshefsky L., Richards A.L., Harington C.A., and Davis C.M. Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacol 90 (1986) 468-470
21. nd ed (1992), Williams & Wilkins, Baltimore
22. Laaksonen M., Uutela A., Vartiainen E., Jousilahti Pekka, Helakorpi S., and Puska P. Development of smoking by birth cohort in the adult population in eastern Finland 1972-1997. Tob. Control 8 (1999) 161-168
23. Levin E.D., and Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl.) 138 (1998) 217-230
24. Lohr J.B., and Flynn K. Smoking and schizophrenia. Schizophr. Res. 8 (1992) 93-102
25. Miller R.R. Effects of smoking on drug action. Clin. Pharmacol. Ther. 22 (1977) 749-756
26. Peto R., Lopez A.D., Boreham J., Thun M., Heath Jr. C., and Doll R. Mortality from smoking worldwide. Br. Med. Bull. 52 (1996) 12-21
27. Salokangas R.K.R., Honkonen T., and Stengård E. Discharged schizophrenia patients in the community-implications for service development. A follow-up study of schizophrenia patients discharged from Finnish mental hospitals in 1982, 1986, 1990 and 1994. Psychiatria Fennica 32 Suppl. 2 (2001) 111-122
28. Salokangas R.K.R., Saarijärvi S., Taiminen T., Lehto H., Niemi H., Ahola V., et al. Effect of smoking on neuroleptics in schizophrenia. Schizophr. Res. 23 (1997) 55-60
29. Salokangas R.K.R., and Saarinen S. Deinstitutionalisation and schizophrenia in Finland: discharged patients and their care. A follow-up study of schizophrenic patients discharged from Finnish mental hospitals in 1982, 1986 and 1990. Schizophr. Bull. 24 (1998) 457-467
30. Salokangas R.K.R., Stengård E., Honkonen T., Koivisto A.-M., and Saarinen S. Sairaalasta yhteiskuntaan. (From Hospital to the Community; Finnish report) (2000), STAKES, Raportteja 248, Helsinki
31. Salokangas R.K.R., Vilkman H., Ilonen T., Taiminen T., Bergman J., Haaparanta M., et al. High levels of dopamine activity in the basal ganglia of cigarette smokers. Am. J. Psychiatry 157 (2000) 632-634
32. Strand J.-E., and Nybäck H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. Eur. Psychiatry 20 (2005) 50-54
33. Ziedonis D.M., Kosten T.R., Glazer W.M., and Frances R.J. Nicotine dependence and schizophrenia. Hosp Com Psychiatry 45 (1994) 204-206